Clorox (NYSE:CLX) Price Target Cut to $150.00 by Analysts at Citigroup

Clorox (NYSE:CLXFree Report) had its price target trimmed by Citigroup from $155.00 to $150.00 in a report released on Wednesday morning, Benzinga reports. The firm currently has a neutral rating on the stock.

CLX has been the topic of several other reports. Morgan Stanley reissued an equal weight rating and issued a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. Barclays reduced their target price on Clorox from $148.00 to $136.00 and set an underweight rating on the stock in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft reduced their target price on Clorox from $155.00 to $151.00 and set a hold rating on the stock in a report on Wednesday, April 17th. UBS Group reduced their target price on Clorox from $164.00 to $159.00 and set a neutral rating on the stock in a report on Wednesday. Finally, The Goldman Sachs Group assumed coverage on Clorox in a report on Friday, March 1st. They set a sell rating and a $140.00 price objective on the stock. Four investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of Hold and a consensus target price of $149.38.

Get Our Latest Analysis on CLX

Clorox Trading Down 5.6 %

CLX stock opened at $139.64 on Wednesday. Clorox has a 1-year low of $114.68 and a 1-year high of $178.21. The firm has a market cap of $17.33 billion, a P/E ratio of 221.65, a P/E/G ratio of 2.35 and a beta of 0.43. The business’s 50 day moving average is $149.00 and its 200-day moving average is $143.10. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company’s revenue was down 5.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.51 EPS. Equities analysts anticipate that Clorox will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.44%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 761.92%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Fortitude Family Office LLC bought a new stake in shares of Clorox in the 4th quarter valued at $29,000. Venturi Wealth Management LLC increased its position in shares of Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after buying an additional 145 shares in the last quarter. Northwest Financial Advisors bought a new position in Clorox during the 4th quarter worth about $29,000. Core Wealth Advisors Inc. bought a new position in Clorox during the 4th quarter worth about $29,000. Finally, First United Bank & Trust acquired a new position in shares of Clorox during the 4th quarter worth about $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.